SpringerLink
Log in

Antineoplastics/aclarubicin/unspecified GCSF

Various toxicities and lack of efficacy: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wan C-L, et al. Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series. Leukemia and Lymphoma 62: 3300-3303, No. 13, Jan 2021. Available from: URL: https://www.tandfonline.com/loi/ilal20

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/aclarubicin/unspecified GCSF. Reactions Weekly 1957, 52 (2023). https://doi.org/10.1007/s40278-023-39177-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-39177-3

Search

Navigation